WYSONG, A.; SOMANI, A. .; IBRAHIM, . S.; CAÑUETO, J. .; FITZGERALD, A. .; SIEGEL, J. .; PRASAI, A.; GOLDBERG, M.; FARBERG, A.; KASPRZAK, J. .; BRODLAND, D. .; KOYFMAN, S.; ARRON, S. . Incorporating the 40-Gene Expression Profile (40-GEP) Test within Each Clinicopathologic Staging System Improves Metastatic Risk-Stratification in Patients Diagnosed with Cutaneous Squamous Cell Carcinoma (cSCC) and One or More High Risk Factors. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 1, p. s334, 2024. DOI: 10.25251/skin.8.supp.334. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/2455. Acesso em: 3 jul. 2024.